Literature DB >> 18775773

Cunninghamella--a microbial model for drug metabolism studies--a review.

Sepuri Asha1, Maravajhala Vidyavathi.   

Abstract

Drug metabolism studies constitute an important and necessary step in the evaluation of drug efficacy and safety. In vivo drug metabolism studies suffer from many disadvantages. Hence there is a rise in validation of in vitro microbial models. This review describes the transformation studies of drugs by the fungus, Cunninghamella and correlating them with the metabolism/biotransformation in animal systems and providing technical methods to develop microbial models. Emphasis is laid on the potential of Cunninghamella fungus to mimic mammalian drug biotransformations and to use as in vitro model for drug metabolism studies and for further toxicological and pharmacological studies of metabolites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775773     DOI: 10.1016/j.biotechadv.2008.07.005

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  28 in total

1.  Production of drug metabolites by immobilised Cunninghamella elegans: from screening to scale up.

Authors:  Laura Quinn; Rita Dempsey; Eoin Casey; Ayla Kane; Cormac D Murphy
Journal:  J Ind Microbiol Biotechnol       Date:  2015-02-10       Impact factor: 3.346

2.  Processing of NMR and MS metabolomics data using chemometrics methods: a global tool for fungi biotransformation reactions monitoring.

Authors:  Cécile Palaric; Serge Pilard; Jean-Xavier Fontaine; Julien Boccard; David Mathiron; Sébastien Rigaud; Dominique Cailleu; François Mesnard; Yoann Gut; Tristan Renaud; Alain Petit; Jean-Yves Beaumal; Roland Molinié
Journal:  Metabolomics       Date:  2019-07-25       Impact factor: 4.290

3.  Structural Elucidation of Metabolites of Synthetic Cannabinoid UR-144 by Cunninghamella elegans Using Nuclear Magnetic Resonance (NMR) Spectroscopy.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; Shanlin Fu
Journal:  AAPS J       Date:  2018-03-08       Impact factor: 4.009

4.  Biotransformation of flurbiprofen by Cunninghamella species.

Authors:  Jessica Amadio; Katherine Gordon; Cormac D Murphy
Journal:  Appl Environ Microbiol       Date:  2010-07-23       Impact factor: 4.792

5.  Microbial biotransformation of furosemide for environmental risk assessment: identification of metabolites and toxicological evaluation.

Authors:  Hugo Olvera-Vargas; Sébastien Leroy; Michael Rivard; Nihal Oturan; Mehmet Oturan; Didier Buisson
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-25       Impact factor: 4.223

6.  Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; My Ann Nguyen; Jane Cameron; Shanlin Fu
Journal:  AAPS J       Date:  2017-04-28       Impact factor: 4.009

Review 7.  Microbial Interventions in Bioremediation of Heavy Metal Contaminants in Agroecosystem.

Authors:  Veni Pande; Satish Chandra Pandey; Diksha Sati; Pankaj Bhatt; Mukesh Samant
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

8.  Microbial Metabolism of Atovaquone and Cytotoxicity of the Produced Phase I Metabolite.

Authors:  Eliane de Oliveira Silva; Natália Dos Santos Gonçalves; Raquel Alves Dos Santos; Niege Araçari Jacometti Cardoso Furtado
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

9.  Controlled Production of Zearalenone-Glucopyranoside Standards with Cunninghamella Strains Using Sulphate-Depleted Media.

Authors:  Jeroen Peters; Edward Ash; Arjen Gerssen; Ruud Van Dam; Maurice C R Franssen; Michel W F Nielen
Journal:  Toxins (Basel)       Date:  2021-05-21       Impact factor: 4.546

10.  Cunninghamella as a microbiological model for metabolism of histamine H(3) receptor antagonist 1-[3-(4-tert-butylphenoxy)propyl]piperidine.

Authors:  Elżbieta Pękala; Paulina Kubowicz; Dorota Łażewska
Journal:  Appl Biochem Biotechnol       Date:  2012-09-16       Impact factor: 2.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.